CEREBRUM Intent-to-Use Trademark Application for Neurological Pharmaceuticals

USPTO issued a Notice of Intent-to-Use trademark application TM99400475 for CEREBRUM covering Class 42 technology services. The goods/services description includes providing pharmaceutical information for treatment of neurological disorders and CNS disorders, consulting services in neurological pharmaceuticals, and medical/scientific research information.

This is a published trademark application notice; third parties have an opportunity to oppose the registration during the opposition period. Pharmaceutical companies and drug manufacturers developing neurological treatments should review the application to assess potential conflicts with existing marks. No immediate compliance action is required, but entities with similar marks may consider filing an opposition.